Neogen Corporation (NEOG)

Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World ScrewwormJune 18, 2026 8:45 AM
Business Wire Company expands availability of FIFRA 2(ee) recommendations to counter threat Neogen Corporation (NASDAQ: NEOG), an innovative leader in food and animal safety solutions, today announced the expanded availability of FIFRA* Section 2(ee) recommendations for the use of Prozap® Insectrin X Concentrate and Prozap® Screw Worm and Ear Tick Aerosol as part of New World Screwworm (NWS) response efforts. These recommendations provide ranchers, livestock producers, and horse owners with an additional option to support fly management efforts. In Texas, the Texas Department of Agriculture has approved Section 2(ee) recommendations for these products. Neogen is also making Section 2(ee) recommendations available in Florida, providing producers in both states with additional tools to incorporate into broader fly management programs. While NWS was largely eradicated from the United States decades ago, recent developments have increased industry attention on prevention, vigilance, and effective fly control programs. Whether addressing emerging concerns such as NWS or routine pest pressures, prevention and prompt wound management remain important components of herd health programs. Neogen offers a broad range of insect control solutions to help producers manage insect challenges across a variety of livestock environments. Among them, Prozap® Screw Worm and Ear Tick Aerosol can help protect wounds from flies and maggots while controlling a variety of labeled pests, including ticks, gnats, and lice. Prozap® Insectrin X Concentrate can be incorporated into broader fly management programs to help manage fly populations in and around livestock facilities. USDA officials have emphasized the importance of continued vigilance, monitoring, and information sharing as the situation evolves. Although NWS has received increased attention in recent weeks, livestock producers continue to manage a range of insect-related challenges, including horn flies, stable flies, face flies, ticks, and lice, that can affect animal health, welfare, and productivity. “Producers face insect pressure every season, making prevention and routine monitoring essential parts of herd management,” said Kirk Ramsey, DVM, MS, Professional Services Veterinarian with Neogen. “Integrated fly control programs, prompt wound management, and regular observation of animals can help producers address ongoing insect challenges while remaining prepared for emerging concerns.” Neogen encourages livestock producers to work closely with their veterinarians and animal health advisors to develop insect management programs tailored to their operations and regional needs. For more information about Neogen's livestock insect control solutions, visit: https://info.neogen.com/Prozap or contact your Neogen representative. *FIFRA refers to the Federal Insecticide, Fungicide, and Rodenticide Act. These recommendations are made as permitted under FIFRA Section 2(ee). Users must be in possession of the applicable recommendation at the time of pesticide application and comply with all product label directions and applicable state requirements. **Important Use Information The FIFRA Section 2(ee) recommendations for Prozap® Insectrin X Concentrate and Prozap® Screw Worm and Ear Tick Aerosol permit certain uses that do not appear on the EPA-approved product label. This recommendation has not been submitted to or approved by the U.S. Environmental Protection Agency (EPA). Users must have the 2(ee) recommendation in their possession at the time of application and must follow all applicable directions, restrictions, and precautions on the EPA-registered product label. About Neogen Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers. Safe Harbor Statement This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to the ability of Prozap® Screw Worm and Ear Tick Aerosol and Prozap® Insectrin X Concentrate to help ranchers, livestock producers, and horse owners fight against New World Screwworm; the ability of Prozap® Screw Worm and Ear Tick Aerosol to help protect wounds from flies and maggots while controlling a variety of labeled pests, including ticks, gnats and lice; and the ability of Prozap® Insectrin X Concentrate to be incorporated into broader control programs to help manage fly populations in and around livestock facilities. These “forward-looking statements” are management’s present expectations of future events as of the date hereof and are subject to a number of known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially and adversely from those anticipated. These risks include, but are not limited to risks relating to the integration of the 3M Food Safety business, risks related to potential tax benefits realized through the 3M transaction, risks related to tariffs and other trade measures, risks related to our international operations and expansion into new geographic markets, risks related to identified material weaknesses in our internal control over financial reporting, risks related to promoting internal growth and identifying and integrating acquisitions, risks related to failure of our systems infrastructure and security breaches of our information systems, risks related to disruption in our manufacturing and service operations, risks related to disruption of third-party package delivery services or pricing increases, risks related to dependence on key suppliers, risks related to the use of distributors for product sales, risks related to the development of new products and technologies, risks related to our ability to maintain a positive reputation, risks related to customer loss, risks related to increased raw material costs, risks related to anti-bribery, trade control, trade sanctions, and anti-corruption laws, risks related to changes in domestic and foreign laws and regulations, risks related to tax audits and changes in tax laws in different jurisdictions, risks related to deterioration in profitability, cash flow, and asset impairments, risks related to competition, risks related to agricultural marketplace, risks related to our substantial indebtedness, risks related to the outcomes of litigation and other legal proceedings, risks related to our ability to obtain and protect intellectual property, risks related to patent infringement challenges, risks related to governmental regulation, risks related to our ability to attract and retain key personnel, risks related to product or service liability claims, risks related to changing political conditions, risks related to climate change, risks related to our inability to meet stakeholder expectations around environmental, social, and governance objectives, risks related to tax legislation, and other factors discussed under the heading “Risk Factors” contained in Item 1A of the company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on July 30, 2025, as well as any updates to those risk factors filed from time to time in the company’s Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Neogen is not under any obligation, and it expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20260618868773/en/ Media contact:
Lauren White
PR@neogen.com Investor Contact:
Scott Gleason
(435) 395-0254
sgleason@neogen.com
Original: Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm

Neogen tops estimates as food safety segment drives growthApril 9, 2026 10:56 AM
IH Market News
Neogen Corp. (NASDAQ:NEOG) reported third-quarter results on Thursday that came in ahead of analyst forecasts, supported by strong performance in its food safety business.Shares of the company rose 1.16% in premarket trading following the announcement.The food safety and animal health company posted adjusted earnings per share of $0.09, surpassing the consensus estimate of $0.06 by $0.03.Quarterly revenue totaled $211.2 million, exceeding analysts’ expectations of $204.49 million, although it declined 4.4% compared with $221.0 million in the same quarter last year.Growth was led by the Food Safety segment, which recorded 4.0% core revenue growth and continued the momentum seen in the previous quarter. Regional expansion was strongest in Latin America and Europe. In contrast, the Animal Safety segment saw core revenue decline 8.7%, largely due to supply challenges involving third-party vendors.Neogen also raised its fiscal 2026 full-year revenue outlook, now expecting revenue between $857 million and $860 million. The midpoint of $858.5 million is above the consensus estimate of $850.9 million. Previously, the company had guided for revenue in the range of $845 million to $855 million.Adjusted EBITDA for the quarter reached $48.2 million, with a margin of 22.8%, representing a 110 basis point improvement compared with the second quarter despite lower revenue.The improved margins were driven by disciplined cost management, with adjusted operating expenses declining 9% sequentially. The reduction reflects the full impact of a workforce reduction implemented during the first quarter.Adjusted net income for the quarter totaled $19.4 million. Neogen reiterated its full-year adjusted EBITDA guidance of approximately $175 million and said it expects to generate positive free cash flow in fiscal 2026.The company also confirmed that its Petrifilm manufacturing transition remains on schedule for November 2027, with early product validation tests delivering encouraging results.Neogen Corporation stock price

Original: Neogen tops estimates as food safety segment drives growth

Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026March 30, 2026 2:50 PM
Business Wire
Neogen® Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening of the market on Thursday, April 9, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company’s performance for the third-quarter of fiscal year 2026.


The conference call can be accessed by dialing:

Toll-Free - North America: 1-800-549-8228

International: (+1) 646-564-2877

Conference ID: 70064#


The live webcast can be accessed through Neogen’s Investor Relations webpage, neogen.com/investor-relations, under the “Events & Presentations” subheading.


A replay of the conference call and webcast will be available shortly following the conclusion of the call and can be accessed by dialing:

Toll-Free - North America: (1) 888-660-6264

International: (+1) 646-517-3975

Passcode: 70064 #


It will also be available on Neogen’s Investor Relations website at neogen.com/investor-relations.


About Neogen


Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260326431610/en/
Investor Contact

Scott Gleason

(435) 395-0254

sgleason@neogen.com


Media Contact:

Lauren White

lwhite@neogen.com


Original: Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026

Zoetis shares slip after announcing $160M acquisition of Neogen genomics unitMarch 2, 2026 11:14 AM
IH Market News
Shares of Zoetis Inc (NYSE:ZTS) edged 1.1% lower to $129.72 in premarket trading on Monday after the animal health company revealed plans to acquire the animal genomics division of Neogen Corporation (NASDAQ:NEOG) in a deal valued at $160 million.The transaction will give Zoetis access to Neogen’s genetic testing capabilities and data analytics platforms, which the company intends to use to enhance disease prediction and enable more tailored healthcare solutions for animals.Neogen’s genomics business operates five laboratories located in the United States, Brazil, Australia, China and the United Kingdom, along with an additional office in Canada, serving customers across more than 120 countries worldwide.Zoetis said the acquisition is expected to close during the second half of calendar year 2026, subject to customary conditions.The company’s shares had gained approximately 4.2% during 2025 prior to Monday’s decline.Zoetis stock price

Original: Zoetis shares slip after announcing $160M acquisition of Neogen genomics unit

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile SolutionJanuary 28, 2026 6:27 PM
Business Wire
Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following intraarticular injections of this product, which is inconsistent with its labeled, intended use. To date, Neogen has not received reports of adverse events when used in a manner consistent with the labeled use.


While the company’s investigation into this issue is ongoing, out of an abundance of caution the 2mL/20mg product vials are also being recalled. The company is proactively working with the FDA on this matter.


Risk Statement: This product is labeled as a sterile solution, but due to microbial contamination of certain lots, the recalled lots should no longer be considered sterile. Vials that contain a microbial contaminant potentially result in infection in the animal. The risk is particularly acute when used as an intraarticular injection (which is inconsistent with its labeled, intended use). There also is risk if used according to the label as a topical wound management system in surgical wounds, burns, ulcers, and autograft procedures. To date, Neogen has not received reports of adverse events when used in a manner consistent with the labeled use.


The product is intended for use as a topical wound management system and is packaged in vials of 2mL/20 mg (UPC Code 726087089386) and 10mL/50mg (UPC Code 726087089393).


The subject product lots within expiry include the following:


2 mL/20 mg lot numbers: 0236735, 0236736, 0336746, 0336747, 0536760, 0536761, 0636768, 0636769, 0836792, 0836785, 0836788, 0836789, 0936794, 0936795, 1036801, 1036802, 1036803, 1036804, 1136807, 1136808, 0246837, 0246838, 4L001B, 4L002


10 mL/50 mg lot numbers: 0136731, 0736777, 0346843, 5A001


Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution was distributed nationwide to animal health distributors and veterinarians.


Neogen is notifying its distributors and direct customers by email and is arranging for return of all recalled products. Anyone that has HYCOAT which is being recalled should discontinue use and quarantine product.


Customers with questions regarding this recall can contact Neogen Animal Safety Customer Support Monday through Friday, 8AM-5PM ET at 859-254-1221 or via email at AnimalHealth@neogen.com for return shipping instructions. Customers can work through their distributor for product returns.


Veterinarians that have experienced any problems that may be related to using this product should report to the FDA's Center for Veterinary Medicine on FORM FDA 1932a, “Veterinary Adverse Experience, Lack of Effectiveness or Product Defect Report.”



Download and submit Form FDA 1932a available at https://www.fda.gov/reportanimalae, or



Contact FDA at 1-888-FDA-VETS to request this form.



This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


No other Neogen products are affected by this field action.


About Neogen


Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260128021369/en/
PR@Neogen.com


Original: Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

NEOG...$6.50...🥳

georgie18

Member Level
Re: georgie18 post# 681622

Monday, May 12, 2025 9:34:06 AM

Post#
682020
of 682105
NEOG...$6.34...🥳...Getting some traction here...Open Gap to fill in the $7 range...

georgie18

Member Level
Re: georgie18 post# 392993

Wednesday, May 07, 2025 3:53:56 PM

Post#
393154
of 393211
NEOG...$5.93...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...

georgie18

Member Level
Re: georgie18 post# 681173

Sunday, May 04, 2025 10:21:06 AM

Post#
681230
of 681622
NEOG...$5.75...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...

georgie18

Member Level
Re: georgie18 post# 392776

Friday, May 02, 2025 1:31:58 PM

Post#
392962
of 392992
NEOG...$5.51...Picher Squeeze Breakout here...🥳

georgie18

Member Level
Re: georgie18 post# 680431

Monday, April 28, 2025 3:29:57 PM

Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳

georgie18

Member Level
Re: georgie18 post# 392678

Friday, April 25, 2025 9:40:38 AM

Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳

georgie18

Member Level
Re: None

Friday, April 25, 2025 8:15:28 AM

Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...

NEOG...$6.34...🥳...Getting some traction here...Open Gap to fill in the $7 range...

georgie18

Member Level
Re: georgie18 post# 392993

Wednesday, May 07, 2025 3:53:56 PM

Post#
393154
of 393211
NEOG...$5.93...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...

georgie18

Member Level
Re: georgie18 post# 681173

Sunday, May 04, 2025 10:21:06 AM

Post#
681230
of 681622
NEOG...$5.75...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...

georgie18

Member Level
Re: georgie18 post# 392776

Friday, May 02, 2025 1:31:58 PM

Post#
392962
of 392992
NEOG...$5.51...Picher Squeeze Breakout here...🥳

georgie18

Member Level
Re: georgie18 post# 680431

Monday, April 28, 2025 3:29:57 PM

Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳

georgie18

Member Level
Re: georgie18 post# 392678

Friday, April 25, 2025 9:40:38 AM

Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳

georgie18

Member Level
Re: None

Friday, April 25, 2025 8:15:28 AM

Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...

NEOG...$5.93...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...

georgie18

Member Level
Re: georgie18 post# 681173

Sunday, May 04, 2025 10:21:06 AM

Post#
681230
of 681622
NEOG...$5.75...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...

georgie18

Member Level
Re: georgie18 post# 392776

Friday, May 02, 2025 1:31:58 PM

Post#
392962
of 392992
NEOG...$5.51...Picher Squeeze Breakout here...🥳

georgie18

Member Level
Re: georgie18 post# 680431

Monday, April 28, 2025 3:29:57 PM

Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳

georgie18

Member Level
Re: georgie18 post# 392678

Friday, April 25, 2025 9:40:38 AM

Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳

georgie18

Member Level
Re: None

Friday, April 25, 2025 8:15:28 AM

Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...

NEOG...$5.75...🥳...Own $5.08 range to $5.20 Range...Took some profit on Friday...

georgie18

Member Level
Re: georgie18 post# 392776

Friday, May 02, 2025 1:31:58 PM

Post#
392962
of 392992
NEOG...$5.51...Picher Squeeze Breakout here...🥳

georgie18

Member Level
Re: georgie18 post# 680431

Monday, April 28, 2025 3:29:57 PM

Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳

georgie18

Member Level
Re: georgie18 post# 392678

Friday, April 25, 2025 9:40:38 AM

Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳

georgie18

Member Level
Re: None

Friday, April 25, 2025 8:15:28 AM

Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...

NEOG...$5.51...Picher Squeeze Breakout here...🥳

georgie18

Member Level
Re: georgie18 post# 680431

Monday, April 28, 2025 3:29:57 PM

Post#
680633
of 681173
NEOG...Added $5.08s to $5.12s...🥳

georgie18

Member Level
Re: georgie18 post# 392678

Friday, April 25, 2025 9:40:38 AM

Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳

georgie18

Member Level
Re: None

Friday, April 25, 2025 8:15:28 AM

Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...

NEOG...Added $5.08s to $5.12s...🥳

georgie18

Member Level
Re: georgie18 post# 392678

Friday, April 25, 2025 9:40:38 AM

Post#
392685
of 392775
NEOG...$5.14...🥳...300,000 Volume in already...🥳

georgie18

Member Level
Re: None

Friday, April 25, 2025 8:15:28 AM

Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...

NEOG...$5.14...🥳...300,000 Volume in already...🥳

georgie18

Member Level
Re: None

Friday, April 25, 2025 8:15:28 AM

Post#
680404
of 680430
NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...

NEOG...$5.20...🥳...https://schrts.co/qkuyFWyn ...Pincher Squeeze in play here...Open Gap in the $7 Range...

NEOG 10Q due 4/9

NEOG completes merger with 3M’s food-safety business:

https://www.prnewswire.com/news-releases/neogen-completes-3m-food-safety-business-merger-301616453.html

NEOG shareholders approve merger with 3M's food-safety business:

https://finance.yahoo.com/news/neogen-shareholders-approve-proposals-required-173000054.html

NEOG reports solid FY4Q22 results:

https://finance.yahoo.com/news/neogen-announces-record-revenues-fiscal-124500146.html

No CC due to pending merger with 3M’s food-safety business, which is on track for closing in Sep 2022.

Costs related to the 3M merger are expected to be $9-11M in FY4Q22 (the current quarter), roughly the same as FY3Q22. In FY3Q22, there were 14,000 hours(!) of meetings between NEOG and 3M personnel.

NEOG does not issue revenue or EPS guidance.

NEOG FY3Q22* CC transcript:

https://www.fool.com/earnings/call-transcripts/2022/03/24/neogen-neog-q3-2022-earnings-call-transcript/

*FY3Q22 consisted of the three months ending 2/28/22. NEOG’s fiscal year ends on May 31.

NEOG FY3Q22 financials:

https://www.prnewswire.com/news-releases/neogen-announces-third-quarter-results-301509892.html Net income for the third quarter was $5,443,000, or $0.05 per share, adversely impacted by $10.6 million of professional fees incurred in connection with Neogen's plan to combine 3M's Food Safety business with the company's existing operations, which was announced on December 14, 2021. Excluding the 3M deal-related costs, net income for the quarter would have been $13,600,000, or $0.13 per share, compared to $13,377,000, or $0.12 per share, in the previous year's third quarter. No CC.

NEOG FY2Q22 CC transcript:

https://www.fool.com/earnings/call-transcripts/2021/12/21/neogen-corporation-neog-q2-2022-earnings-call-tran/

NEOG FY2Q22 results—EPS $0.10 down from $0.15 in prior year due to $9.3M expenses related to recently announced merger with 3M spinoff:

https://finance.yahoo.com/news/neogen-announces-second-quarter-results-134500549.html

FY2Q22 sales grew 13% YoY, but much of this growth was due to currency; organic YoY sales growth was 1%.

MMM-NEOG CC slides:

https://s24.q4cdn.com/834031268/files/doc_presentations/2021/12/NEOGEON-and-3M's-Food-Safety-Combination-Investor-Presentation.pdf

NEOG to merge with 3M’s spun-off food-safety business in $9.3M deal:

https://www.sec.gov/Archives/edgar/data/0000066740/000119312521356172/d264913dex99.htm

The combination is structured as a Reverse Morris Trust that is non-taxable to 3M shareholders, who will receive shares of NEOG but no cash. The closing is expected in 3Q22.

Had this stock back at 2.00, wow she's come far!

$NEOG DD Notes ~ http://www.ddnotesmaker.com/NEOG

bullish very long term

$NEOG recent news/filings

## source: finance.yahoo.com

Wed, 08 Oct 2014 21:07:30 GMT ~ NEOGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/141008/neog8-k.html
*********************************************************

Sat, 04 Oct 2014 00:08:14 GMT ~ 10-Q for Neogen Corp.


read full: http://www.companyspotlight.com/routers/headline/18881/10004/6399840?cp_code=YAH1&1412381294
*********************************************************

Fri, 03 Oct 2014 17:31:35 GMT ~ NEOGEN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders


read full: http://biz.yahoo.com/e/141003/neog8-k.html
*********************************************************

Wed, 01 Oct 2014 20:45:06 GMT ~ NEOGEN CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/141001/neog8-k.html
*********************************************************

Wed, 01 Oct 2014 17:00:00 GMT ~ Neogen acquires BioLumix

[PR Newswire] - LANSING, Mich., Oct. 1, 2014 /PRNewswire/ -- Neogen Corporation (NEOG) announced today that, effective Sept. 30, it has acquired all the outstanding stock of BioLumix, Inc., an Ann Arbor, Mich.-based manufacturer and marketer of automated systems for the detection of microbial contaminants. The BioLumix business will be consolidated with Neogen's closely related Soleris® technology, which is widely used for the detection of spoilage organisms in several food industries, as well as the nutraceutical market. "Combining of the Soleris and BioLumix technologies, market bases, and outstanding technical staffs will greatly enhance both businesses and offer significant labor saving rapid solutions for the food, pharmaceutical, and personal care businesses," said James Herbert, Neogen's chief executive officer and chairman.

read full: http://finance.yahoo.com/news/neogen-acquires-biolumix-170000134.html
*********************************************************


$NEOG charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$NEOG company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/NEOG/company-info
Ticker: $NEOG
OTC Market Place: Not Available
CIK code: 0000711377
Company name: Neogen Corp.
Company website: http://www.neogen.com
Incorporated In: MI, USA


$NEOG share structure

## source: otcmarkets.com

Market Value: $1,625,873,839 a/o Oct 28, 2014
Shares Outstanding: 36,926,501 a/o Aug 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 1.06
$NEOG extra dd links

Company name: Neogen Corp.
Company website: http://www.neogen.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NEOG+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NEOG+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NEOG+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/news - http://finance.yahoo.com/q/h?s=NEOG+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NEOG/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NEOG+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NEOG
DTCC (dtcc.com): http://search2.dtcc.com/?q=Neogen+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Neogen+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Neogen+Corp.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.neogen.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.neogen.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.neogen.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NEOG
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000711377&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NEOG&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NEOG
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NEOG+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NEOG+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NEOG
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NEOG
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NEOG+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NEOG/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NEOG+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NEOG.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NEOG
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NEOG/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NEOG/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NEOG
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NEOG
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NEOG:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NEOG
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NEOG



$NEOG DD Notes ~ http://www.ddnotesmaker.com/NEOG

Neogen Corporation Launches NeoSEEK System

http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66&symbol=NEOG.O×tamp=20110721124500

~ Tuesday! $NEOG ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $NEOG ~ Earnings expected on Tuesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=NEOG&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=NEOG&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=NEOG
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=NEOG#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=NEOG+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=NEOG
Finviz: http://finviz.com/quote.ashx?t=NEOG
~ BusyStock: http://busystock.com/i.php?s=NEOG&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=NEOG >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets a diverse line of products dedicated to food and animal safety. The Company’s food safety segment consists primarily of diagnostic test kits and complementary products (dehydrated culture media) marketed by company sales personnel in North America, the United Kingdom and other parts of Europe, Mexico and Brazil, and by distributors elsewhere to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, genetic modifications, ruminant by-products, drug residues, pesticide residues and general sanitation concerns. Neogen’s animal safety segment is engaged in the development, manufacture and marketing of pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals and diagnostic products and genetic testing services for the worldwide animal safety market.


http://www.google.com/finance?q=NEOG